What type of Parkinson's disease is correlated with mild to moderate asymmetrically reduced tracer concentration in the left frontal, temporal, and parietal regions, anterior cingulate gyrus, bilateral (b/l) thalami, and cerebellar regions on a Positron Emission Tomography (PET) Computed Tomography (CT) scan in a patient likely over 60 years old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PET-CT Pattern Correlates with Dementia with Lewy Bodies (DLB)

The described PET-CT pattern of asymmetrically reduced tracer concentration in the left frontal, temporal, and parietal regions, anterior cingulate gyrus, bilateral thalami, and cerebellar regions most strongly correlates with Dementia with Lewy Bodies (DLB), not a specific "type" of Parkinson's disease. This pattern represents a parkinsonian syndrome with dementia rather than classical Parkinson's disease.

Key Distinguishing Features on PET-CT

The imaging pattern you describe contains several hallmark features of DLB:

  • Temporal, parietal, and cerebellar hypometabolism is characteristic of DLB, with the cerebellar involvement being particularly distinctive 1.

  • Occipital lobe involvement (which may be implied by the posterior distribution) is a distinguishing feature that separates DLB from Alzheimer's disease, where occipital hypometabolism is typically absent 1.

  • Bilateral thalamic involvement aligns with the subcortical pathology seen in DLB and other Lewy body disorders 1.

Critical Diagnostic Consideration: The Anterior Cingulate Pattern

The anterior cingulate gyrus involvement you describe is important but requires clarification:

  • If the posterior cingulate is relatively preserved compared to other regions (the "cingulate island sign"), this strongly supports DLB over Alzheimer's disease 1, 2.

  • The cingulate island sign (preservation of FDG metabolism in the posterior cingulate gyrus) is a specific biomarker for DLB with high specificity, and its presence is associated with preserved memory and processing speed 1.

  • In contrast, Alzheimer's disease typically shows hypometabolism in the posterior cingulate and precuneus 1.

DLB vs. Parkinson's Disease Dementia

This is DLB rather than Parkinson's disease with dementia based on the clinical rule:

  • DLB is diagnosed when dementia occurs within 12 months of motor symptom onset 3.

  • Parkinson's disease dementia (PDD) is diagnosed when dementia develops more than 12 months after established motor symptoms 3.

  • Both conditions share similar pathology (alpha-synuclein-positive Lewy bodies) but differ in clinical presentation timing 4, 3.

Confirmatory Testing Recommendations

To solidify the diagnosis of DLB:

  • Dopamine transporter (DaT) SPECT imaging should be performed to assess nigrostriatal dopaminergic degeneration, which shows reduced striatal uptake with 78% sensitivity and 90% specificity for differentiating DLB from Alzheimer's disease 5, 6.

  • A normal DaT scan shows symmetric comma-shaped uptake in caudate nuclei and putamina; loss of this pattern with reduced putaminal uptake indicates dopaminergic neuron loss consistent with DLB 5, 6.

  • The American College of Radiology recommends FDG-PET before DaT scanning for cost considerations, but DaT scanning provides additional diagnostic value when clinical features overlap 5.

Clinical Correlation Required

The imaging findings must be correlated with clinical features of DLB:

  • Fluctuating cognitive impairment with variations in alertness and attention 4, 3.

  • Spontaneous recurrent visual hallucinations that are typically well-formed and detailed 4, 3.

  • Parkinsonism that is usually akineto-rigid without classical rest tremor, and is mild to moderately severe 4, 3.

  • Visuospatial deficits and frontal executive dysfunction are more prominent than memory impairment early in the disease 4, 3.

Important Pitfall to Avoid

Do not confuse this with frontotemporal dementia (FTD), which can show asymmetric frontal and temporal hypometabolism:

  • FTD demonstrates bilateral frontal hypoperfusion with sparing of the precuneus and occipital lobes 1.

  • FTD shows asymmetric involvement of anterior temporal lobes, prefrontal cortices, insula, anterior cingulate, striatum, and thalamus in behavioral variant FTD 1.

  • However, cerebellar involvement and the pattern of thalamic involvement favor DLB over FTD 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic and Management Approach for Left Posterior Cingulate Gyrus Low Volume

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

How to diagnose dementia with Lewy bodies: state of the art.

Movement disorders : official journal of the Movement Disorder Society, 2005

Research

Dementia with Lewy bodies: diagnosis and management.

International journal of geriatric psychiatry, 2001

Guideline

DaT Scan Diagnostic Criteria and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Measuring Dopamine in Clinical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.